Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Gelesis Holdings Inc's Business Segments
Gelesis Holdings Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 1
Regions Reported
-
Gelesis Holdings Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue by Product & Service Category - FY
- Product Revenue, Net100%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product Revenue, Net | $ 1 | 100% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Gelesis Holdings Inc
Gelesis Holdings Inc. is a biotechnology company that specializes in the development of hydrogel-based therapeutics for the treatment of various health conditions. The company was founded in 2006 and is headquartered in Boston, Massachusetts.
Gelesis is focused on the development of novel therapeutics that leverage the unique properties of hydrogels, which are highly absorbent materials capable of expanding in the presence of water. The company's proprietary technology involves designing and manufacturing hydrogels that can be ingested orally and expanded in the gastrointestinal tract to induce feelings of fullness, reduce appetite, and promote weight loss.
The flagship product of Gelesis is Plenity, an oral hydrogel capsule approved by the U.S. Food and Drug Administration (FDA) for weight management in overweight and obese adults. Plenity works by expanding in the stomach, creating a feeling of fullness that helps individuals control their portion sizes and reduce overall calorie intake. It is different from traditional weight loss medications as it is non-stimulant, non-systemic, and does not get absorbed into the bloodstream.
Gelesis also conducts research and development activities to explore the potential applications of hydrogels in other areas of healthcare. These include the development of hydrogel-based products for the management of diabetes, non-alcoholic fatty liver disease, and gastrointestinal disorders.
In addition to its core business of developing hydrogel-based therapeutics, Gelesis actively collaborates with academic institutions, pharmaceutical companies, and government organizations to expand its research and commercialization efforts. The company has a strong intellectual property portfolio with numerous patents filed and granted worldwide, providing a solid foundation for its innovative products and technologies.
Gelesis is committed to addressing the global health challenges associated with obesity and related metabolic disorders. With a team of experienced scientists, researchers, and professionals, the company strives to develop safe, effective, and novel treatment options that can revolutionize weight management and improve overall health outcomes.
Gelesis is focused on the development of novel therapeutics that leverage the unique properties of hydrogels, which are highly absorbent materials capable of expanding in the presence of water. The company's proprietary technology involves designing and manufacturing hydrogels that can be ingested orally and expanded in the gastrointestinal tract to induce feelings of fullness, reduce appetite, and promote weight loss.
The flagship product of Gelesis is Plenity, an oral hydrogel capsule approved by the U.S. Food and Drug Administration (FDA) for weight management in overweight and obese adults. Plenity works by expanding in the stomach, creating a feeling of fullness that helps individuals control their portion sizes and reduce overall calorie intake. It is different from traditional weight loss medications as it is non-stimulant, non-systemic, and does not get absorbed into the bloodstream.
Gelesis also conducts research and development activities to explore the potential applications of hydrogels in other areas of healthcare. These include the development of hydrogel-based products for the management of diabetes, non-alcoholic fatty liver disease, and gastrointestinal disorders.
In addition to its core business of developing hydrogel-based therapeutics, Gelesis actively collaborates with academic institutions, pharmaceutical companies, and government organizations to expand its research and commercialization efforts. The company has a strong intellectual property portfolio with numerous patents filed and granted worldwide, providing a solid foundation for its innovative products and technologies.
Gelesis is committed to addressing the global health challenges associated with obesity and related metabolic disorders. With a team of experienced scientists, researchers, and professionals, the company strives to develop safe, effective, and novel treatment options that can revolutionize weight management and improve overall health outcomes.
Gelesis Holdings Inc. is a biotechnology company focused on developing innovative solutions for weight management and metabolic health through its proprietary products. The company primarily targets obesity and related health issues with its flagship products, aimed at providing effective treatment options. Below is a detailed exploration of the segments, products, and services that Gelesis Holdings Inc. offers.
Segments
1. Weight Management:
This segment revolves around developing products that help individuals manage their weight effectively. It addresses a growing public health concern, as obesity has become a significant issue globally, leading to various chronic health conditions.
2. Metabolic Health:
Gelesis emphasizes promoting overall metabolic health. This includes not just weight loss, but also improving parameters like blood sugar levels, insulin sensitivity, and cholesterol profiles, thereby contributing to overall well-being.
3. Chronic Disease Management:
The companys focus extends to obesity-related chronic diseases such as diabetes, hypertension, and cardiovascular diseases. Through their products, they aim to create a healthier society by mitigating the onset or progression of these conditions.
Products
1. Plenity:
- Overview: Plenity is Gelesiss flagship product, designed to aid in weight management. It is a prescription medical device that utilizes a unique gelatin capsule technology to provide a sensation of fullness.
- Mechanism of Action: It contains cellulose-based microscopic particles that expand in the stomach, creating a feeling of satiety, thereby helping users control their food intake.
- Indications: Plenity is indicated for adults with a body mass index (BMI) of 25 to 40, providing a potential option for those who are overweight or moderately obese.
- Administration: The product is taken orally with water, typically before meals, allowing individuals to incorporate it easily into their daily routine.
2. Clinical Development Pipeline:
- Gelesis is engaged in ongoing research and development to expand its product offerings within the weight management and metabolic health domains. This pipeline includes potential new formulations and applications of their existing technology.
- Research Focus: The clinical trials aim to evaluate the safety and efficacy of new products, including those tailored for specific populations or conditions, such as women, children, or individuals with diabetes.
Services
1. Patient Education and Support:
- Gelesis provides educational resources and support programs to help patients understand their weight management journey. This includes materials on lifestyle changes, nutrition, exercise, and the role of Plenity in achieving weight loss goals.
2. Healthcare Professional Training:
- The company actively engages with healthcare providers to ensure they have the necessary information to prescribe Plenity effectively. This involves educational workshops, webinars, and materials outlining the science behind the product and its appropriate use.
3. Health Monitoring:
- Gelesis may also explore partnerships or integrations with health technology companies to enhance ongoing health monitoring for users of Plenity. This could include devices or applications that help track dietary intake, weight changes, and general health metrics.
4. Regulatory and Compliance Services:
- Given the nature of its products, Gelesis is committed to ensuring regulatory compliance and the safety of its offerings. This involves rigorous adherence to FDA regulations, conducting clinical trials as required, and maintaining high standards of quality assurance across its product development processes.
Conclusion
Gelesis Holdings Inc. stands at the intersection of biotechnology and wellness, focusing primarily on innovations in weight management and metabolic health. Through its flagship product, Plenity, and an ongoing commitment to research and development, the company aims to provide comprehensive solutions that not only promote weight loss but also improve overall health outcomes for individuals managing obesity and its related conditions. Their educational and support services further enhance the user experience, positioning them as a prominent player in the weight management landscape.
Segments
1. Weight Management:
This segment revolves around developing products that help individuals manage their weight effectively. It addresses a growing public health concern, as obesity has become a significant issue globally, leading to various chronic health conditions.
2. Metabolic Health:
Gelesis emphasizes promoting overall metabolic health. This includes not just weight loss, but also improving parameters like blood sugar levels, insulin sensitivity, and cholesterol profiles, thereby contributing to overall well-being.
3. Chronic Disease Management:
The companys focus extends to obesity-related chronic diseases such as diabetes, hypertension, and cardiovascular diseases. Through their products, they aim to create a healthier society by mitigating the onset or progression of these conditions.
Products
1. Plenity:
- Overview: Plenity is Gelesiss flagship product, designed to aid in weight management. It is a prescription medical device that utilizes a unique gelatin capsule technology to provide a sensation of fullness.
- Mechanism of Action: It contains cellulose-based microscopic particles that expand in the stomach, creating a feeling of satiety, thereby helping users control their food intake.
- Indications: Plenity is indicated for adults with a body mass index (BMI) of 25 to 40, providing a potential option for those who are overweight or moderately obese.
- Administration: The product is taken orally with water, typically before meals, allowing individuals to incorporate it easily into their daily routine.
2. Clinical Development Pipeline:
- Gelesis is engaged in ongoing research and development to expand its product offerings within the weight management and metabolic health domains. This pipeline includes potential new formulations and applications of their existing technology.
- Research Focus: The clinical trials aim to evaluate the safety and efficacy of new products, including those tailored for specific populations or conditions, such as women, children, or individuals with diabetes.
Services
1. Patient Education and Support:
- Gelesis provides educational resources and support programs to help patients understand their weight management journey. This includes materials on lifestyle changes, nutrition, exercise, and the role of Plenity in achieving weight loss goals.
2. Healthcare Professional Training:
- The company actively engages with healthcare providers to ensure they have the necessary information to prescribe Plenity effectively. This involves educational workshops, webinars, and materials outlining the science behind the product and its appropriate use.
3. Health Monitoring:
- Gelesis may also explore partnerships or integrations with health technology companies to enhance ongoing health monitoring for users of Plenity. This could include devices or applications that help track dietary intake, weight changes, and general health metrics.
4. Regulatory and Compliance Services:
- Given the nature of its products, Gelesis is committed to ensuring regulatory compliance and the safety of its offerings. This involves rigorous adherence to FDA regulations, conducting clinical trials as required, and maintaining high standards of quality assurance across its product development processes.
Conclusion
Gelesis Holdings Inc. stands at the intersection of biotechnology and wellness, focusing primarily on innovations in weight management and metabolic health. Through its flagship product, Plenity, and an ongoing commitment to research and development, the company aims to provide comprehensive solutions that not only promote weight loss but also improve overall health outcomes for individuals managing obesity and its related conditions. Their educational and support services further enhance the user experience, positioning them as a prominent player in the weight management landscape.